一种RNA结合蛋白IGF2BP3的小分子抑制剂显示出抗白血病活性
Amit K Jaiswal1, Georgia M Scherer2, Michelle L Thaxton1
1Department of Pathology and Laboratory Medicine, University of California, Los Angeles, CA.
Haematologica
|November 27, 2025
概括
研究人员确定了I3IN-002,它是一种强大的小分子抑制剂,向胎儿内蛋白IGF2BP3 (胰岛素样生长因子2 mRNA结合蛋白3). 这种化合物有效地抑制白血病细胞的生长,并在体内表现出抗白血病活性.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 胰岛素样生长因子2 mRNA结合蛋白3 (IGF2BP3) 是一种在B级急性淋巴细胞白血病中过度表达的胎儿蛋白.
- IGF2BP3在白血病发生和mRNA稳态中发挥着关键作用,使其成为一个有前途的治疗点.
- 目前,IGF2BP3的小分子抑制剂没有临床使用.
研究的目的:
- 确定IGF2BP3.3.的新型小分子抑制剂.
- 评估已识别的化合物的抗白血病活性.
- 描述化合物的作用机制.
主要方法:
- 生物化学查,其次是基于细胞的反查,以确定抑制剂.
- 在体外测试以评估蛋白质-RNA相互作用抑制和细胞生长抑制.
- 在实体研究中,使用了小鼠MLL-Af4白血病的合成移植模型.
主要成果:
- 鉴定I3IN-002作为IGF2BP3.3的强有力的抑制剂.
- I3IN-002在白血病细胞系中表现出一致的细胞生长抑制活性,细胞周期的改变和亡的增加.
- I3IN-002在体内表现出强烈的抗白血病活性,并且在小鼠中耐受良好.
结论:
- I3IN-002是迄今为止报告的IGF2BP3最强大的抑制剂.
- I3IN-002通过破坏IGF2BP3与目标mRNA的相互作用和改变基因表达而起作用.
- 发现I3IN-002为开发用于治疗白血病的强效和选择性IGF2BP3抑制剂提供了基础.
相关概念视频
02:15Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
01:23RNA Interference
27.7K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.7K
01:23Types of RNA
72.4K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
72.4K
02:30siRNA - Small Interfering RNAs
18.3K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.3K